NASDAQ: ONCYOncolytics Biotech Inc Stock Ownership - Who owns Oncolytics Biotech?
Insider buying vs selling
Have Oncolytics Biotech Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jared Kelly | Chief Executive Officer | 2026-03-12 | 5,050 | $0.96 | $4.85kBuy |
| James T. Parsons | Director | 2026-03-11 | 10,000 | $1.03 | $10.30kBuy |
| Allison Hagerman | VP Product Development | 2026-02-12 | 10,000 | $0.83 | $8.30kBuy |
| Thomas Charles Heineman | Chief Medical Officer | 2026-02-12 | 12,132 | $0.83 | $10.03kBuy |
| Jared Kelly | Chief Executive Officer | 2026-02-12 | 29,500 | $0.84 | $24.84kBuy |
| Bernd R. Seizinger | Director | 2026-02-12 | 40,000 | $0.85 | $33.88kBuy |
| Deborah Margaret Brown | Director | 2026-02-12 | 25,000 | $0.85 | $21.25kBuy |
| Kirk Look | Chief Financial Officer | 2026-02-12 | 12,000 | $0.84 | $10.10kBuy |
| Wayne Pisano | Director | 2026-02-12 | 30,000 | $0.85 | $25.35kBuy |
| Patricia S. Andrews | Director | 2026-02-12 | 35,400 | $0.86 | $30.30kBuy |
ONCY insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ONCY insiders and whales buy or sell their stock.
ONCY Shareholders
What type of owners hold Oncolytics Biotech Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Renaissance Technologies LLC | 0.60% | 715,838 | $572.67k | Institution |
| Bernd R. Seizinger | 0.48% | 566,991 | $453.59k | Insider |
| Wayne Pisano | 0.41% | 492,414 | $393.93k | Insider |
| Sandbox Financial Partners LLC | 0.34% | 400,000 | $320.00k | Institution |
| Kirk Look | 0.24% | 287,515 | $230.01k | Insider |
| Thomas Charles Heineman | 0.24% | 282,818 | $226.25k | Insider |
| Seeds Investor LLC | 0.22% | 258,306 | $206.64k | Institution |
| Angela Holtham | 0.15% | 183,639 | $146.91k | Insider |
| Tocqueville Asset Management LP | 0.12% | 149,000 | $119.20k | Institution |
| Everhart Financial Group Inc | 0.12% | 138,161 | $110.53k | Institution |
ONCY vs Biotech Stocks
Oncolytics Biotech Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.